4//SEC Filing
HOLMLUND JON T 4
Accession 0000899243-20-014034
CIK 0001563577other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:20 PM ET
Size
13.9 KB
Accession
0000899243-20-014034
Insider Transaction Report
Form 4
HOLMLUND JON T
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2020-05-20$1.07/sh+969$1,037→ 969 total - Exercise/Conversion
Stock Option
2020-05-20−969→ 6,870 totalExercise: $1.07Exp: 2023-01-22→ Common Stock (969 underlying) - Exercise/Conversion
Stock Option
2020-05-21−1,174→ 5,696 totalExercise: $1.07Exp: 2023-01-22→ Common Stock (1,174 underlying) - Sale
Common Stock
2020-05-20$12.00/sh−969$11,628→ 0 total - Sale
Common Stock
2020-05-21$12.00/sh−1,174$14,088→ 0 total - Exercise/Conversion
Common Stock
2020-05-21$1.07/sh+1,174$1,256→ 1,174 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2019
- [F2]The option has fully vested and is currently exercisable.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001227367
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 5:20 PM ET
- Size
- 13.9 KB